
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : JAG201
Therapeutic Area : Neurology
Study Phase : Preclinical
Sponsor : Deerfield Management
Deal Size : Undisclosed
Deal Type : Financing
Advanced Medicine Partners Launches for Manufacturing and Testing Advanced Medicines
Details : Proceeds will support CMC efforts for JAG201, a gene therapy in preclinical development for autism spectrum disorder and other neurodevelopmental disorders.
Product Name : Undisclosed
Product Type : Cell & Gene Therapy
Upfront Cash : Undisclosed
January 16, 2024
Lead Product(s) : JAG201
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Sponsor : Deerfield Management
Deal Size : Undisclosed
Deal Type : Financing
